| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.3 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |